Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Am J Gastroenterol. 2022 Feb 15;117(5):769–776. doi: 10.14309/ajg.0000000000001685

Table 6:

12-month risk of hospitalization, corticosteroids, and colectomy based on level on urgency in UC patients followed longitudinally

Clinical Outcome Odds ratio 95% CI
Hospitalization
 No hurry (reference)  —  —
 Hurry 1.57 1.37, 1.81
 Immediately 2.64 2.21, 3.15
 Incontinence 2.97 2.00, 4.42
 Biologic Use 1.21 1.08,1.36
 Female Sex 0.93 0.82,1.06
 Age 0.98 0.98,0.99
 Body mass index 0.99 0.98,1.00
Corticosteroids
 No hurry (reference)
 Hurry 1.28 1.11, 1.47
 Immediately 1.58 1.27, 1.95
 Incontinence 2.37 1.47, 3.82
 Biologic Use 0.97 0.85,1.11
 Female Sex 1.01 0.87,1.17
 Age 0.99 0.99,1.00
 Body mass index 1.00 0.99,1.01
Colectomy
 No hurry (reference)
 Hurry 1.42 1.15,1.75
 Immediately 1.90 1.45,2.50
 Incontinence 3.69 2.35,5.80
 Biologic Use 1.38 1.16,1.64
 Female Sex 0.80 0.66,0.96
 Age 1.00 0.99,1.00
 Body mass index 1.00 0.98,1.01
Full logistic regression model variables are listed in table above

Hospitalization: UC-related hospitalization, Corticosteroids: new reported corticosteroid use, Colectomy: interval report of colectomy, all clinical events within 12 months of symptom report

UC= ulcerative colitis, CI= confidence interval